ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
8.21
+0.52 (6.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
ORIC Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 28.17 | 25.61 | 25.09 | 22.01 | 13.42 | 5.73 | |
| Research & Development | 106.58 | 85.17 | 61.68 | 56.86 | 35.92 | 22.84 | |
| Operating Expenses | 134.75 | 110.78 | 86.77 | 78.87 | 49.34 | 28.57 | |
| Operating Income | -134.75 | -110.78 | -86.77 | -78.87 | -49.34 | -28.57 | |
| Interest & Investment Income | 14.88 | 10.08 | 2.65 | 0.14 | 0.31 | 1.4 | |
| Other Non Operating Income (Expenses) | - | - | - | 0.02 | 0.18 | 0.29 | |
| EBT Excluding Unusual Items | -119.87 | -100.7 | -84.12 | -78.72 | -48.86 | -26.88 | |
| Pretax Income | -119.87 | -100.7 | -89.12 | -78.72 | -73.7 | -26.88 | |
| Net Income | -119.87 | -100.7 | -89.12 | -78.72 | -73.7 | -26.88 | |
| Net Income to Common | -119.87 | -100.7 | -89.12 | -78.72 | -73.7 | -26.88 | |
| Shares Outstanding (Basic) | 66 | 51 | 40 | 38 | 22 | 2 | |
| Shares Outstanding (Diluted) | 66 | 51 | 40 | 38 | 22 | 2 | |
| Shares Change (YoY) | 41.07% | 29.75% | 4.48% | 72.97% | 1055.26% | 9.53% | |
| EPS (Basic) | -1.80 | -1.96 | -2.25 | -2.07 | -3.36 | -14.15 | |
| EPS (Diluted) | -1.80 | -1.96 | -2.25 | -2.07 | -3.36 | -14.15 | |
| Free Cash Flow | -109.9 | -86.54 | -77.22 | -60.48 | -45.94 | -24.3 | |
| Free Cash Flow Per Share | -1.65 | -1.68 | -1.95 | -1.59 | -2.09 | -12.79 | |
| EBITDA | -133.69 | -109.75 | -85.8 | -77.97 | -48.37 | -27.54 | |
| D&A For EBITDA | 1.07 | 1.03 | 0.97 | 0.9 | 0.97 | 1.03 | |
| EBIT | -134.75 | -110.78 | -86.77 | -78.87 | -49.34 | -28.57 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.